Sarpogrelate diminishes changes in energy stores and ultrastructure of the ischemic-reperfused rat heart

Canadian Journal of Physiology and Pharmacology

Volumn 79, Issue 9, 2001, Pages 761-767

  Temsah, R M ^a   Kumamoto, H ^a   Takeda, N ^a   Dhalla, N S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Ischemia reperfusion; Sarpogrelate; Serotonin receptor blockade

Indexed keywords

SARPOGRELATE; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIGH ENERGY PHOSPHATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STRUCTURE ANALYSIS;

EID: 0034756554     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y01-047     Document Type: Article

References (31)

1. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease
2. Ketanserin and ritanserin can reduce reperfusion-induced but not ischemia-induced arrhythmias in anaesthetised rats
3. Pharamchological analysis of the cardiac effect of 5-HT and some 5-HT receptor agonists in the pithed rat
4. Mechanisms of ischemic myocardial cell damage assessed by phosphorous-31 nuclear magnetic resonance
5. Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit
6. 2) receptor antagonists in ischemic rat hearts
7. 5-Hydroxytryptamine induces phospholipase C-mediated hydrolysis of phosphoinositides through 5-hydroxytryptamine-2 receptors in cultured fetal mouse ventricular myocytes
8. Mast cell granule peroxidase: Location, secretion, and SRS-S inactivation
9. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats
10. Acute reoxygenation injury in the isolated rat heart: Role of resident cardiac mast cells
11. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium
12. Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential
13. Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model
14. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes
15. Characterization of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques
16. 2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients
17. Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart
18. Serum vasoconstrictor (serotonin). IV. Isolation and characterization
19. 2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease
20. An analysis of the stimulant effects of 5-hydroxytryptamine on isolated, blood-perfused rat heart
21. Biochemical consequences of electrical pacing in ischemic-reperfused isolated rat hearts
22. Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors
23. High performance liquid chromatography: A rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue
24. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate
25. The transmural progression of the no-reflow phenomenon in globally ischemic hearts
26. Morphological methods for studying heart membranes
27. 2A) receptors
28. 2 receptors
29. Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina
30. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart
31. Serotonin is associated with coronary artery disease and cardiac events